MASHINIi

Mainz Biomed N.V..

MYNZ.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Mainz Biomed N.V. is a molecular genetics diagnostic company specializing in the research, development, and commercialization of innovative, easy-to-use, and affordable diagnostic oncology products. The company's core product is ColoAlert, a non-invasive and accurate at-home screening test for color...Show More

Ethical Profile

Mixed.

Mainz Biomed N.V. is dedicated to improving public health through early, non-invasive cancer detection, notably with ColoAlert for colorectal cancer. This core mission supports better health outcomes and accessible screening. However, the company faces scrutiny over its digital ethics. While CE-IVD certified for ColoAlert and EU-US Data Privacy Framework certified, reports suggest escalating cybersecurity dangers. Critics point to a lack of specific details on encryption, AI ethics, and vulnerability management, raising concerns given its handling of sensitive patient data. For areas like fair pay, environmental impact, and ethical sourcing, there is currently insufficient public information to assess practices.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect-50
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals-60
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Mainz Biomed N.V. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Mainz Biomed N.V. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

-50

None of the company's employees are covered by a collective bargaining agreement.

1
No other specific, quantitative data was found for the remaining KPIs related to fair pay and worker respect.

Fair Trade & Ethical Sourcing

0

No specific, concrete data points or information regarding fair trade certifications, supply chain audits, forced or child labor incidents, supply chain traceability, remediation speed, ethical sourcing clauses in contracts, high-risk materials, or supplier diversity spend were found in the provided articles for Mainz Biomed N.V.

1

Honest & Fair Business

0

No evidence available to assess Mainz Biomed N.V. on Honest & Fair Business.

Kind to Animals

-60

Mainz Biomed undertakes pre-clinical studies on animals for medication safety.

1
While animal studies are required by law for new drug approval, the company's policy is not explicitly stated to prohibit discretionary testing, only that legal mandates override alternatives.
2
The German Animal Welfare Act, one of the strictest globally, governs animal experiments, and EU legislation mandates replacing animal use when new animal-free methods become available.
3
The company is a member of the Berlin-Brandenburg research platform BB3R, which focuses on animal testing alternatives, and the Charité 3R network, founded in 2018, which aims to anchor the 3Rs principle in research.
4
However, the company does not have a public position on animal welfare legislation and is silent on industry standards. The company uses 50,000–100,000 animals annually, with no transparent reduction targets.

No War, No Weapons

0

No evidence available to assess Mainz Biomed N.V. on No War, No Weapons.

Planet-Friendly Business

0

The provided articles do not contain any specific, concrete data points or information related to the Planet-Friendly Business KPIs for Mainz Biomed N.V.

1
The articles primarily focus on financial performance, product development, and corporate updates, explicitly stating that sustainability data is not available or applicable.
2

Respect for Cultures & Communities

0

No specific, concrete data points were found in the provided articles regarding Mainz Biomed N.V.'s performance on any of the KPIs related to Respect for Cultures & Communities.

1
The articles primarily focus on financial and operational information, with explicit statements indicating that metrics related to community engagement, cultural impact, or local involvement are not mentioned or specified.
2

Safe & Smart Tech

0

The company's product, ColoAlert, is CE-IVD certified, and the company is certified under the EU-US Data Privacy Framework (DPF).

1
For secure data transmission, SSL/TLS encryption is utilized.
2
The company's privacy policies grant users rights to information, correction, deletion, restriction of processing, consent revocation, and data portability.
3
Data is retained until its purpose no longer applies and is deleted upon user request.
4
The company states compliance with GDPR and TTDSG (German data protection law).
5
There are no documented incidents of unauthorized data use.
6

Zero Waste & Sustainable Products

0

No specific, concrete data points related to waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability score, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education were found in the provided articles for Mainz Biomed N.V. (MYNZ.US).

1

Own Mainz Biomed N.V.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.